Brief: Vaxart Q1 Net Income USD -24.417 Million
13/05/2024 21:01
May 13 (Reuters) - Vaxart Q1 operating expenses USD 26.251 million. * Q1 operating income USD -24.07 million * Q1 basic EPS USD -0.14 * Q1 pretax profit USD -24.372 million
Recent news on Vaxart
See all newsBrief: Vaxart Expands Intellectual Property Portfolio With European Patent Protecting Proprietary Norovirus Vaccine Technology
Vaxart Q2 revenue falls on lower government contract income
Brief: Vaxart Q2 Net Income USD -13.494 Million
Brief: Vaxart Enters Cooperation Agreement With Stockholder Group And Announces Board And Corporate Governance Enhancements
Vaxart Q1 revenue more than doubles on government contracts